Literature DB >> 26019387

ESTIMATING MEAN SURVIVAL TIME: WHEN IS IT POSSIBLE?

Ying Ding1, Bin Nan2.   

Abstract

For right censored survival data, it is well known that the mean survival time can be consistently estimated when the support of the censoring time contains the support of the survival time. In practice, however, this condition can be easily violated because the follow-up of a study is usually within a finite window. In this article we show that the mean survival time is still estimable from a linear model when the support of some covariate(s) with nonzero coefficient(s) is unbounded regardless of the length of follow-up. This implies that the mean survival time can be well estimated when the support of linear predictor is wide in practice. The theoretical finding is further verified for finite samples by simulation studies. Simulations also show that, when both models are correctly specified, the linear model yields reasonable mean square prediction errors and outperforms the Cox model, particularly with heavy censoring and short follow-up time.

Entities:  

Keywords:  Gehan weights; censored linear regression; empirical process theory; mean survival time; unbounded covariate support

Year:  2015        PMID: 26019387      PMCID: PMC4442028          DOI: 10.1111/sjos.12112

Source DB:  PubMed          Journal:  Scand Stat Theory Appl        ISSN: 0303-6898            Impact factor:   1.396


  6 in total

1.  On the use of survival analysis techniques to estimate medical care costs.

Authors:  R D Etzioni; E J Feuer; S D Sullivan; D Lin; C Hu; S D Ramsey
Journal:  J Health Econ       Date:  1999-06       Impact factor: 3.883

2.  A hybrid Newton-type method for censored survival data using double weights in linear models.

Authors:  Menggang Yu; Bin Nan
Journal:  Lifetime Data Anal       Date:  2006-08-18       Impact factor: 1.588

3.  Doubly penalized buckley-james method for survival data with high-dimensional covariates.

Authors:  Sijian Wang; Bin Nan; Ji Zhu; David G Beer
Journal:  Biometrics       Date:  2007-08-03       Impact factor: 2.571

4.  Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.

Authors:  Yufan Zhao; Donglin Zeng; Mark A Socinski; Michael R Kosorok
Journal:  Biometrics       Date:  2011-03-08       Impact factor: 2.571

5.  A SIEVE M-THEOREM FOR BUNDLED PARAMETERS IN SEMIPARAMETRIC MODELS, WITH APPLICATION TO THE EFFICIENT ESTIMATION IN A LINEAR MODEL FOR CENSORED DATA.

Authors:  Ying Ding; Bin Nan
Journal:  Ann Stat       Date:  2011       Impact factor: 4.028

6.  HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.

Authors:  A David Paltiel; Kenneth A Freedberg; Callie A Scott; Bruce R Schackman; Elena Losina; Bingxia Wang; George R Seage; Caroline E Sloan; Paul E Sax; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

  6 in total
  2 in total

1.  Deep learning for survival outcomes.

Authors:  Jon Arni Steingrimsson; Samantha Morrison
Journal:  Stat Med       Date:  2020-04-13       Impact factor: 2.373

2.  Deep Neural Networks For Predicting Restricted Mean Survival Times.

Authors:  Lili Zhao
Journal:  Bioinformatics       Date:  2021-01-05       Impact factor: 6.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.